Buy Synriam 150 mg/750 mg (Arterolane + Piperaquine) – Effective Malaria Treatment

Synriam is a fixed‑dose combination containing Arterolane 150 mg and Piperaquine 750 mg, manufactured by Sun Pharma to treat acute uncomplicated Plasmodium falciparum malaria—especially in chloroquine-resistant regions ([turn0search4], [turn0search3]).

How It Works

Arterolane disrupts parasite metabolism via heme detox interference, while piperaquine provides sustained activity by accumulating in the parasite digestive vacuole and blocking heme crystallization ([turn0search2], [turn0search19], [turn0search5]).

Uses & Benefits

• Treats uncomplicated falciparum malaria, including drug‑resistant strains.
• Once-daily dosing over three days (each tablet), supporting high adherence.
• Rapid parasite clearance with prevention of recrudescence in most patients ([turn0search2]).

Dosage & Administration

• Administer three doses: Day 1 (diagnosis), Day 2, Day 3—one tablet each day with food for improved absorption. Swallow whole; do not chew or crush ([turn0search2], [turn0search4]).
• If vomiting occurs within 1 hour of dosing, repeat the dose as advised ([turn0search2], [turn0search1]).

Side Effects & Warnings

• Common: headache, nausea, vomiting, abdominal pain, dizziness, fatigue, loss of appetite, cough ([turn0search3], [turn0search1]).
• QT prolongation risk—avoid in patients with known heart rhythm disorders or those on QT‑prolonging drugs ([turn0search1], [turn0search6]).

Precautions & Interactions

• Not recommended in pregnancy or breastfeeding due to limited safety data ([turn0search1], [turn0search4]).
• Use with caution in patients with liver or kidney impairment; consult a physician before use ([turn0search0], [turn0search4]).
• Avoid concurrent use of CYP3A4 inhibitors (e.g. ketoconazole) and QT‑prolonging medications (e.g., halofantrine, cisapride) ([turn0search3], [turn0search1]).
• May cause dizziness or fatigue—avoid driving until effects are known ([turn0search3], [turn0search1]).

Worldwide Shipping

Ships globally with discreet packaging and full tracking. Prescription required. Delivery typically within 6–15 business days.

📌 Frequently Asked Questions (FAQs)

1. What is Synriam used for?

Synriam treats acute uncomplicated falciparum malaria, including chloroquine-resistant strains, using a novel fixed‑dose combination for rapid clearance ([turn0search3], [turn0search2]).

2. How should I take it?

Take one tablet once daily for three days with food. Swallow whole. Do not crush or chew. If vomiting occurs within an hour, repeat the dose as prescribed ([turn0search2], [turn0search1]).

3. What are the common side effects?

Mild effects include headache, nausea, vomiting, abdominal discomfort, dizziness, loss of appetite, fatigue, and cough. Most effects resolve after treatment completion ([turn0search3], [turn0search1]).

4. Are there serious risks or interactions?

QT prolongation risk mandates caution in patients with cardiac conditions or on other QT-prolonging drugs. Discuss all medications and medical history with your doctor ([turn0search1], [turn0search6]).

5. Is Synriam safe in pregnancy or kidney/liver disease?

Not recommended in pregnancy or breastfeeding. Use cautiously with liver or kidney impairment and under medical supervision ([turn0search1], [turn0search4]).